Vera Therapeutics (VERA) Shares Outstanding (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Shares Outstanding (Entity) data on file, last reported at $71.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 12.48% year-over-year to $71.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $71.7 million (up 12.48% YoY) and the FY2025 annual result came in at $71.3 million, up 12.13% from the prior year.
• Shares Outstanding (Entity) climbed to $71.7 million in Q1 2026, from $71.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $71.7 million in Q1 2026 to a low of $26.8 million in Q1 2022.
• A 5-year average of $49.9 million and a median of $54.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 6842.44% — and 2025, when it advanced 12.13%.
• Tracing VERA's Shares Outstanding (Entity) over 5 years: stood at $27.8 million in 2022, then surged by 59.89% to $44.5 million in 2023, then jumped by 42.98% to $63.6 million in 2024, then grew by 12.13% to $71.3 million in 2025, then advanced by 0.65% to $71.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $71.7 million (Q1 2026), $71.3 million (Q4 2025), and $63.9 million (Q3 2025), per Business Quant data.